Skip to main content

Table 15 Anti-proliferative activity of b1 in human cancer cell lines

From: Therapeutic potential of heterocyclic pyrimidine scaffolds

Compound

Human cancer cell lines

Origin

Designation

48 h-MTT GI50 (µM) ± SD

b1

Colon carcinoma

HCT-116

0.79 ± 0.08

Breast carcinoma

MCF-7

0.64 ± 0.08

 

MDA-MB468

1.51 ± 0.34

Lung carcinoma

A549

2.01 ± 0.55

Ovarian carcinoma

A2780

1.00 ± 0.11

Cervical carcinoma

HeLa

0.90 ± 0.07

Pancreatic carcinoma

Miacapa-2

1.25 ± 0.26